Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/26/2025

Treatment of Concurrent Streptococcal Pharyngitis and Influenza

Influenza Management

  • The American Thoracic Society recommends that antiviral therapy is NOT initiated for influenza at 5 days post-symptom onset, as the window for effective treatment has closed 1, 2, 3, 4
  • Guidelines specify that individuals should only be considered for antiviral treatment if they have been symptomatic for two days or less 1, 2, 3
  • The standard treatment schedule for influenza is oseltamivir 75 mg every 12 hours for five days, but this is only effective when started within 48 hours 1, 2, 3
  • Exception: Hospitalized patients who are severely ill, particularly if immunocompromised, may benefit from antiviral treatment started more than 48 hours from disease onset, though evidence is lacking 1, 2, 3

Antibiotic Selection and Monitoring

  • Standard streptococcal pharyngitis antibiotics (penicillin/amoxicillin) do NOT provide coverage for influenza-related bacterial complications 1, 2
  • Do not routinely add broader antibiotics for uncomplicated influenza without pneumonia, even in the presence of strep pharyngitis 1, 2, 5
  • Consider broader coverage (co-amoxiclav or tetracycline) only if the patient develops worsening symptoms suggesting influenza-related pneumonia: recrudescent fever or increasing dyspnea 1, 2, 6
  • Watch for signs of influenza-related bacterial superinfection, which typically develops 4-5 days after initial influenza symptoms 5:

Supportive Care

  • Antipyretics and fluids for symptomatic relief 6
  • Aspirin should not be used in children due to Reye's syndrome risk 6